The New Autism: One Family’s Perspective

Abstract

Get full access to this article

View all access options for this article.

References

Balzola, F.A. , Castellino, F. , et al. (1997). IgM antibodies against measles virus in patients with inflammatory bowel disease: A marker of virus-related disease? European Journal of Gastroenterology and Hepatology, 7, 661-663.

Bitnun, A. , Shannon, P. , et al. (1999). Measles inclusion-body encephalitis caused by the vaccine strain of measles. Clinical Infectious Disease, 29(4), 855-861.

California Department of Developmental Services.

Comi, A.M. , Zimmerman, A.W. , Frye, V.H. , Law, P.A. , & Peeden, J.N. (1999). Familial clustering of autoimmune disorders and evaluation of medical risk factors in autism. Journal of Child Neurology, 14(6), 388-394.

Deykin, E.Y. , & MacMahon, B. (1979). Viral exposure and autism. American Journal of Epidemiology, 109, 628-638.

Furlano, R.I. , Anthony, A. , Day, R. , et al. (2001). Colonic CD8 and T-cell infiltration with epithelial damage in children with autism. Journal of Pediatrics, 138, 366-372.

Hadjivassiliou, M. , Grunewald, R.D. , Chattopadhyay, A.K. , et al. (1998). Clinical, radiological, neurophysical and neuropathological characteristics of gluten ataxia. Lancet, 352, 1582-1585. [Medline]

Jiripinyo, J.M. , Magoffin, R.L. , Lennette, E.H. , & Herndon, R.M. (1967). Additional evidence of relationship between subacute inclusion body encephalitis and measles virus. Lancet, ii, 129-131.

Jyonouchi, H. , Sun, S. , & Le, H. (2001). Innate and adaptive immune responses in children with regressive autism: Evaluation of the effects of environment factors including vaccination. Journal of Allergy and Clinical Immunology: Part 2, 107(2).

10.

Kawashima, H. , Mori, T. , Kashiwagi, Y. , Takekuma, K. , Hoshika, A. , & Wakefield, A.J. (2000). Detection and sequencing of measles virus from peripheral mononuclear cells from patients with inflammatory bowel disease and autism. Digestive Diseases and Sciences, 45, 723-729.

11.

Kaye, J.A. , Melero-Montes, M.M. , & Jick, H. (2001). Mumps, measles and rubella vaccine and the incidence of autism recorded by general practitioners: A time trend analysis. BMJ, 322, 460-463.

12.

Knivsberg, A.M. , Wiig, K. , Lind, G. , Nodland, M. , & Reichelt, K.L. (1990). Dietary intervention in autistic syndromes. Brain Dysfunction, 3, 315-327.

13.

Medical Research Council. (2001, Autumn). Report on Autism.

14.

Megson, M. (2000). Is autism a G-alpha protein defect reversible with natural vitamin A? US Congressional Testimony, April 6.

15.

Mehl-Madrona, L. A look at opioid excess theories. Available: http://www.healingarts.org/children/

16.

Montgomery, S.M. , Morris, D.L. , Pounder, R.E. , & Wakefield, A.J. (1999). Paramomyxovirus in childhood and subsequent inflammatory bowel disease. Gastroenterology, 116, 796-803.

17.

Peltola, H. , Patja, A. , Leinikki, P. , Valle, M. , Davidkin, I. , & Paunio, M. (1998). No evidence for measles, mumps and rubella vaccine associated inflammatory bowel disease or autism in a 14 year prospective study. Lancet, 351, 1327-1328.

18.

Plesner, A.-M. , Hansen, F.J. , Taadon, K. , Nielson, L.H. , Larsen, C.B. , & Pederson, E. (2000). Gait disturbance interpreted as cerebellar ataxia after MMR vaccination at 15 months of age: A follow-up study. Acta Paediatrica, 89, 58-63.

19.

Plesner, R.A. (1995). Gait disturbance after measles mumps rubella vaccine. Lancet, 345, 316.

20.

Ring, A. , Barak, Y. , & Ticher, A. (1997). Evidence for an infectious aetiology in autism. Pathophysiology, 4, 1485-1488.

21.

Roger, J. (2001, March). Autism and prevalence (focusing on the UK). Presentation to the All Party Parliamentary Group on Autism.

22.

Rollens, Rick, Personal correspondence pertaining to the incidence of autism in California, August 2002.

23.

Scott, F.J., Baron-Cohen, S., Bolton, P., & Brayne, C. (2002). Brief report: Prevalence of autism spectrum conditions in children aged 5-11 in Cambridgeshire, UK. Submitted.

24.

Shattock, P. (1990). Role of neuropeptides in autism and their relationships with classical neurotransmitters. Brain Dysfunction, 3, 328-346.

25.

Shah, A.S. , Peppercorn, M.A. , & Pallotta, J.A. (1998). Autoimmune (Hashimoto’s) thyroiditis asscoiated with Crohn’s disease. Journal of Clinical Gastroenterology, 26, 117-120.

26.

Taylor, B.M.E. , Farringdon, C.P. , Petropoulos, M.-C. , Favot-Mayaud, I. , Li, J. , & Waight, P.A. (1999). Autism and measles, mumps and rubella vaccine: No epidemiological evidence for a causal association. Lancet, 353, 2026-2029.

27.

Troika, W. Ohio Department of Education, personal correspondence with F.E. Yazbak.

28.

Uhlmann, V. , Martin, C. , Sheils, O. , O’Donovan, M. , Bermingham, N. , Ring, M. , & O’Leary, J.J. (2000). Measles virus (MV) in reactive lympho-nodular hyperplasia and ileo-colitis of children. Journal of Pathology, 190 (Suppl.), 33A.

29.

United States Department of Education. Figures on rates of autism, 1987-present. Available: http://www.IDEAdata.org/tables/ar_aa2.htm

30.

United States Department of Education. Numbers of children aged 6-21 served by IDEA (Individuals with Disabilities Education Act). Available: http://www.IDEAdata.org/tables/ar_aa2.htm

31.

Wakefield, A.J. , Anthony, A. , Murch, S.H. , Thomson, M. , Montgomery, S.M. , Davies, S. , O’Leary, J.J. , Berelowitz, M. , & Walker-Smith, J.A. (2000). Enterocolitis in children with developmental disorders. American Journal of Gastroenterology, 95, 2285-2295.

32.

Wakefield, A.J. , Anthony, A. , Schepelmann, S. , Murch, S.H. , Montgomery, S.M. , & Walker- Smith, J.A. (1998). Persistent measles virus infection and immunodeficiency in children with autism, ileo-colonic lymphoid nodular hyperplasia and non-specific colitis. Gut, 42 (Suppl. 1), A86.

33.

Wakefield, A.J. , & Montgomery, S.M. (1999). Crohn’s disease: The case for measles virus. Italian Journal of Gastroenterology, 31, 247-254.

34.

Wakefield, A.J. , & Montgomery, S.M. (2000). Measles, mumps and rubella vaccine: Through a glass darkly. Adverse Drug Reactions and Toxicological Review, 19, 265-283.

35.

Wakefield, A.J. , Murch, S.H. , Anthony, A. , et al. (1998). Ileal(lymphoid nodular hyperplasia, non-specific colitis and pervasive developmental disorder in children. Lancet, 351, 1327-1328. [Medline]

36.

Waring, R.H. (2000). Sulphation in autism. Autism Europe Congress 2000, Glasgow, May 19-21.

37.

Weibel, R.E. , Caserta, V. , Benor, D.E. , & Evans, G. (1998). Acute encephalopathy followed by permanent brain injury or death associated with further attenuated measles vaccine: A review of claims submitted to the National Vaccine Injury Compensation Program. Pediatrics, 101(3), 383-387.

38.

Yazbak, F. (2001). Letter to the Editor. Adverse Drug Reaction and Toxicology Review, 20(1) 47.

39.

Yazbak, F. Autism: Is there a vaccine connection: Part I. Vaccination after delivery. Available: htttp://www.garynull.com/Documents/autism99b.htm

40.

Yazbak, F. Autism: Is there a vaccine connection: Part II. Vaccination during pregnancy. Available: http://www.garynull.com/Documents/autism99b2.htm

41.

Yazbak, F. Autism: Is there a vaccine connection: Part III. Vaccination around a pregnancy. Available: http://www.garynull.com/Documents/autism99b3.htm

42.

Yazbak, F. Edward, M.D. (2000, June). Presentation to the American Academy of Pediatrics.

43.

Yazbak, F. Edward , & Yazbak, K. (2002). Live virus vaccination near a pregnancy: Flawed politics, tragic results. Medical Hypothesis Journal, 59(3), 283-288.

44.

Yonk, L.J. , Warren, R.P. , Burger, R. , et al. (1990). CD4+ helper T cell depression in autism. Immunology Letters, 25, 341-346.

45.

Zecca, T. , Graffino, D. , Oleske, J. , et al. (1998, March). Elevated rubeola titers in autistic children. Presentation to the National Institute of Health, Washington DC.